3rd Annual MHRA Paediatric Regulation Seminar. Thursday 11 February 2010 - London.
Better Regulation of Medicines Initiative (BROMI): Improvements in Detailed Descriptions of Pharmacovigilance System (DDPS) assessments.
Draft guidance for comment on the UK's arrangements under the hospital exemption scheme for advanced therapy medicinal products.
Marketing Authorisation applications for medicines using the Decentralised procedure (DCP) with the UK as Reference Member State (RMS): New or earlier slots available in all therapeutic areas.
Members announced for the MHRA’s Agency Board.
MHRA Annual Report and Accounts 2008/09.
MLX 356 - Outcome of consultation on proposals for regularising the position of those mixing and administering medicines in palliative care.
MLX 357 - Outcome of consultation on measures to strengthen the medicines’ supply chain and reduce risk from counterfeit medicines.
Public consultation (MLX 360): Latent UK marketing authorisation (MA) applications.
Public consultation (MLX 361): The UK proposals on the charging of fees in respect of the European Regulation (EC 1234/2008) on variations to Medicines Marketing Authorisations.
Revised statement on medical and non-medical prescribing and mixing medicines in clinical practice.
Streamlining the approval process of safety variation applications of medicines.
[Links to external webpages]
Healthcare Improvement Scotland gathers the latest in quality improvement, innovation and adopted best practice. This bulletin brings you research, resources and publications from across the international improvement community. Follow our posts and keep up to date on the improvement methodologies, techniques and policies influencing your healthcare.
